Computer modelling of the antithrombin III–heparin–thrombin complex inspired the synthesis of novel glycoconjugates, whose factor Xa and thrombin inhibitory activites can be adjusted in a rational way, leading to anticoagulants with unprecedented characteristics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Heparin (eds Lane, D.A. & Lindahl, U.), Arnold Edward, London; (1989).
Olson, S.E. & Björk, I. Sem. thromb. Hemostas. 20, 373–409 (1994).
Choay, J. et al. Biochem. biophys. Res. Commun. 116, 492–99 (1983).
Thunberg, L., Bäckström, G. & Lindahl, U. Carbohydr. Res. 100, 393–410 (1982).
Olson, S.T. & Bjork, I. J. biol. Chem. 266, 6353–6364 (1991).
van Boeckel, C.A.A. & Petitou, M. Angew. chem. int. ed. Engl. 32, 1671–1690 (1993).
Petitou, M. & van Boeckel, C.A.A. Progr. Chem. Org. Nat. Prod. 60, 143–210 (1992).
Lane, D.A., Denton, J., Flynn, A.M., Thunberg, L., & Lindahl, U. Biochem. J. 218, 725–732 (1984).
Danielsson, A., Raub, E., Lindahl, U. & Björk, I. J. biol. Chem. 261, 15467–15473 (1986).
Schreuder, H.A. et al. Nature struct. Biol. 1, 48–54 (1994).
Carrell, R.W., Stein, P.E., Fermi, G. & Wardell, M.R. Structure 2, 257–270 (1994).
Stein, P.E. & Carrell, R.W. Nature struct. Biol. 2, 96–113 (1995).
Bode, W. et al. EMBO J. 8, 3467–3475 (1989).
Padmanabhan, K. et al. J. molec. Biol. 232, 947–966 (1993).
Mulloy, B., Forster, M.J., Jones, C. & Davies, D.B. Biochem. J. 293, 849–858 (1993).
Grootenhuis, P.D.J. & van Boeckel, C.A.A. J. Am. chem. Soc. 113, 2743–2747 (1991).
van Boeckel, C.A.A., Grootenhuis, P.D.J. & Visser, A. Nature struct. Biol. 1, 423–425 (1994).
Olson, S.T., Halvorson, H.R. & Björk, I. J. biol. Chem. 266, 6342–6352 (1991).
Radoff, S. & Danishefsky, I. J. biol. Chem. 259, 166–172 (1984).
Rosenfeld, L. & Danishefsky, I. J. biol. Chem. 263, 262–266 (1988).
Oscarsson, L.-G., Pejler, G. & Lindahl, U. J. biol. Chem. 264, 296–304 (1989).
Petitou, M. et al. Carbohydr. Res. 167, 67–75 (1987).
Teien, A.N. & Lie, M. Thromb. Res. 10, 399–410 (1977).
Larsen, M.L. Thromb. Res. 13, 285–288 (1978).
Visser, A. et al. Thromb. Haemostas. 65, 1296 (1991).
Gan, Z.R., Li, Y., Chen, Z., Lewis, S.D. & Shafer, J.A. J. biol. Chem. 269, 1301–1305 (1994).
Westerduin, P. et al. Bioorg. med. Chem. 2, 1267 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grootenhuis, P., Westerduin, P., Meuleman, D. et al. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity. Nat Struct Mol Biol 2, 736–739 (1995). https://doi.org/10.1038/nsb0995-736
Issue Date:
DOI: https://doi.org/10.1038/nsb0995-736
This article is cited by
-
The ternary complex of antithrombin–anhydrothrombin–heparin reveals the basis of inhibitor specificity
Nature Structural & Molecular Biology (2004)
-
Synthesis of thrombin-inhibiting heparin mimetics without side effects
Nature (1999)